Editorial content

Read our June 2017 issue.

Our biggest issue of the year is here. Company profiles and features in the edition focus on infectious diseases, vaccines and pharmaceutical dealmaking strategies.

Go to the profile of Raveena Bhambra
Jun 01, 2017
1
0
Upvote 1 Comment

Read our June 2017 issue now.

Go to the profile of Raveena Bhambra

Raveena Bhambra

Editor, BioPharma Dealmakers , Nature Publishing Group

Hello all, I am the Editor of BioPharma Dealmakers, a quarterly publication that assists companies in identifying potential partners in the pharmaceutical and biotechnology industry and appears in both Nature Biotechnology and Nature Reviews Drug Discovery. I am very passionate about the biopharma industry and have over 12 years of experience of working in the field, specifically in dealmaking, partnering and licensing. In my previous roles I have conducted partner searches identifying both products/technologies and partners for clients, and have edited and written dealmaking-focused reports.

No comments yet.